Home > flu360® Overview > Clinical Support > Influenza Burden 65+ years

angled corner
Influenza can have a devastating impact on adults 65 years and older1

While influenza impacts millions of people in the US,2 it disproportionately affects adults 65 years and older.1 flu360® can help address the vaccine needs of those 65 years and older.

In the US, influenza impacts adults 65+ with high hospitalization and death rates.1

The CDC estimates that each year, adults 65+ account for approximately1:

Hospital icon

50%-70%
of influenza-related hospitalizations

icon of EKG readout

70%-85%
of influenza-related deaths

What are the influenza-related complications?

up to

80%

of adults 65+ live with multiple chronic health conditions, many of which are associated with increased risk of influenza-related complications.*3,4

In the first weeks after influenza infection, adults 65+ have an increased risk of:

A first or subsequent
heart attack:

up to

3-5 times

more likely5

A first or subsequent
stroke:

up to

2-3 times

more likely5

Developing pneumonia and bronchitis, the most common complications of influenza5,6

*2010 Medical Expenditure Panel Survey Data (MEPS) from the Agency
for Healthcare Research and Quality (AHRQ).

Flu vaccination in older adult patient
angled corner

In many recent seasons, vaccine effectiveness has been suboptimal in adults 65+ compared to younger adults.† 7-10

angled corner

†Data estimates from the Centers for Disease Control and Prevention from 2016-2020

We're committed to helping reduce the influenza burden through vaccine innovation

Discover Our Adjuvanted TechnologyNext screen

Explore the CSL Seqirus Vaccine Portfolio

ExploreNext screen
ExploreNext screen
ExploreNext screen

Please see Important Safety Information and full US Prescribing Information on each vaccine's respective product page.

References.1. Centers for Disease Control and Prevention. Flu & people 65 years and older. Accessed February 12, 2021. https://www.cdc.gov/flu/highrisk/65over.htm 2. Centers for Disease Control and Prevention. Disease burden of influenza. Accessed October 20, 2020. https://www.cdc.gov/flu/ about/burden/index.html 3. Agency for Healthcare Research and Quality. Multiple chronic conditions chartbook: 2010 medical expenditure panel survey data. Published April 2014. Accessed September 12, 2020. https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/mccchartbook.pdf 4. McElhaney JE, Kuchel GA, Zhou X, Swain SL, Haynes L. T-cell immunity to influenza in older adults: a pathophysiological framework for development of more effective vaccines. Front Immunol. 2016 7:41. doi:10.3389/fimmu.2016.00041 5. National Foundation for Infectious Diseases. Call to action: reinvigorating influenza prevention in US adults age 65 and older. Published September 2016. Accessed September 12, 2020. https://www.nfid.org/wp-content/uploads/2019/08/flu-older-adults.pdf 6. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008 121(4):258-264. doi:10.1016/j.amjmed.2007.10.0 7. Centers for Disease Control and Prevention. Seasonal influenza vaccine effectiveness, 2016-2017. Accessed October 1, 2019. https://www.cdc.gov/flu/vaccines-work/2016-2017.html 8. Centers for Disease Control and Prevention. Seasonal influenza vaccine effectiveness, 2017-2018. Accessed October 1, 2019. https://www.cdc.gov/flu/vaccines-work/2017-2018.html 9. Centers for Disease Control and Prevention. US flu VE data for 2018-2019. Accessed August 19, 2020. https://www.cdc.gov/flu/vaccines-work/2018-2019.html 10. Centers for Disease Control and Prevention. US flu VE data for 2019-2020. Accessed March 4, 2021. https://www.cdc.gov/flu/vaccines-work/2019-2020.html